Intellectual Property

Genetic Signatures Ltd has a broad patent portfolio covering its core technologies that include a number of patent families.

These inventions can be broadly grouped into the following categories:

Current Technology

• Simplification of Genomes for Microbial Detection (3base^®)
  Treating naturally occurring nucleic acids with bisulphite and using the resultant modified nucleic acids to detect pathogens and disease.

Emerging Technologies

To discuss licensing Genetic Signatures' technology, contact [email protected].